Edition:
United Kingdom

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

55.00USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$55.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
214,794
52-wk High
$59.00
52-wk Low
$33.45

Chart for

About

Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended-release topiramate), its two treatments for patients with epilepsy. In... (more)

Overall

Beta: 1.12
Market Cap(Mil.): $2,904.54
Shares Outstanding(Mil.): 51.77
Dividend: --
Yield (%): --

Financials

  SUPN.OQ Industry Sector
P/E (TTM): 36.35 28.57 32.53
EPS (TTM): 1.51 -- --
ROI: 17.13 13.08 12.63
ROE: 29.05 14.80 14.50

BRIEF-Supernus Pharma Reports Q1 Earnings Per Share $0.49

* SUPERNUS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECORD QUARTERLY REVENUE

08 May 2018

BRIEF-Supernus Announces Pricing Of $350 Mln Private Offering Of 0.625 Pct Convertible Senior Notes

* SUPERNUS ANNOUNCES PRICING OF $350 MILLION PRIVATE OFFERING OF 0.625% CONVERTIBLE SENIOR NOTES

15 Mar 2018

BRIEF-Supernus Announces Proposed Private Offering Of $350 Million Of Convertible Senior Notes

* SUPERNUS ANNOUNCES PROPOSED PRIVATE OFFERING OF $350 MILLION OF CONVERTIBLE SENIOR NOTES

13 Mar 2018

BRIEF-Supernus Reports Q4 Earnings Per Share ‍$0.26​

* SUPERNUS ANNOUNCES RECORD FULL YEAR 2017 FINANCIAL RESULTS, EXCEEDING OPERATING EARNINGS GUIDANCE

27 Feb 2018

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $62.11 +0.40
AstraZeneca plc (AZN.L) 5,425.00 +8.00
Eli Lilly And Co (LLY.N) $81.83 -0.24
Shire PLC (SHP.L) 4,218.00 +11.00
Shire PLC (3159084.L) -- --
Smiths Group plc (SMIN.L) 1,716.00 +3.00

Earnings vs. Estimates